These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 37170222)
41. Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer. He R; Man C; Huang J; He L; Wang X; Lang Y; Fan Y Front Genet; 2022; 13():870945. PubMed ID: 35464855 [TBL] [Abstract][Full Text] [Related]
42. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
43. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma. Yin T; Zhao L; Yao S BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168 [TBL] [Abstract][Full Text] [Related]
44. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
45. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer. Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B Front Immunol; 2022; 13():914577. PubMed ID: 35757739 [TBL] [Abstract][Full Text] [Related]
46. Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes. Ding H; Teng Y; Gao P; Zhang Q; Wang M; Yu Y; Fan Y; Zhu L Hum Mol Genet; 2024 Mar; 33(7):563-582. PubMed ID: 38142284 [TBL] [Abstract][Full Text] [Related]
47. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
48. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K Front Immunol; 2021; 12():800268. PubMed ID: 34956238 [TBL] [Abstract][Full Text] [Related]
49. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma. Yu ZL; Zhu ZM Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330 [TBL] [Abstract][Full Text] [Related]
50. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance. Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344 [TBL] [Abstract][Full Text] [Related]
51. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028 [No Abstract] [Full Text] [Related]
52. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response. Jiang H; Ning G; Wang Y; Lv W Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187 [TBL] [Abstract][Full Text] [Related]
53. Construction of a m5C-related long non-coding RNA signature for the prognosis of hepatocellular carcinoma. Lu J; Wang H; Cao W; Chen D; He Z; Xu J Hum Cell; 2023 Mar; 36(2):712-724. PubMed ID: 36520346 [TBL] [Abstract][Full Text] [Related]
54. Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas. Li Y; Li X; Yu Z Front Oncol; 2023; 13():1177120. PubMed ID: 37228500 [TBL] [Abstract][Full Text] [Related]
55. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma. Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992 [TBL] [Abstract][Full Text] [Related]
56. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients. Liu Y; Shen B; Huang T; Wang J; Jiang J PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019 [TBL] [Abstract][Full Text] [Related]
57. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
58. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Huang X; Qiu Z; Li L; Chen B; Huang P Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607 [TBL] [Abstract][Full Text] [Related]
59. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma. Pan J; Huang Z; Xu Y Front Oncol; 2021; 11():657466. PubMed ID: 34195072 [TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]